Table 1 Shuttle walk distance, smoking status and oxygen use of MFT patients (n = 124)
From: Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
Shuttle walk n = 40 | Distance |
Most recent shuttle walk distance | 397 m |
Average pre-walk oxygen saturation | 96% |
Average post-walk oxygen saturation | 87% |
Smoking status n = 124 | Number (%) |
Ex-smoker | 83 (67) |
Non-smoker | 35 (28) |
Current smoker | 3 (2) |
Unknown | 3 (2) |
Average pack years | 33 |
Ambulatory and/or long term oxygen therapy n = 124 | 43 (35) |